Current Neuro-Oncology
Volume
28 Number 2
20 January 2026
Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 2, 20 January
Zeng W, Wang P, Fang S, Ge S, Jia W, Peng S, Wang M, Qin X, Zhang
W, Gao J, Su X, Yuan G, Wu J, Liu Y, Wang Y, Lu H, Mu R, Wu F,
Chang Q, Jin G, Meng F, Zhang J, Liu F.
ON-01,
an engineered recombinant oncolytic herpes simplex virus type-1,
in recurrent glioma: a single-arm, phase 1/2 study.
Neuro
Oncol. 2026 Jan 12:noag005. doi:
10.1093/neuonc/noag005. PMID:
41527280.
Trial
registration ID:
ChiCTR1900022570. ˍ
Gao M, Chen Q, Zhang H, Tian Y, Fu Z, Yan M, Liu C.
Real-world
adverse event profile and signal characteristics of bevacizumab in
glioma: a FAERS-based disproportionality analysis.
Front
Pharmacol. 2026 Jan 13;16:1705451. doi:
10.3389/fphar.2025.1705451. PMID:
41608019. ˍ
El Ghalbouni A, Snijders TJ, Tolboom N, Braat AJAT.
Near
complete response recurrent glioblastoma after treatment with
[131I]-Iodofalan.
Eur
J Nucl Med Mol Imaging. 2026 Jan 14. doi:
10.1007/s00259-025-07742-w. PMID:
41533060. ˍ
Salama
AKS, Wang V, Macrae ER, Park JI, Chen HX, Gray RJ, McShane LM,
Rubinstein LV, Patton D, Williams PM, Hamilton SR, Armstrong DK,
Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP,
Flaherty KT.
Phase
II Study of Dabrafenib and Trametinib in Patients With Tumors With
BRAFV600E
Mutations:
Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131)
Subprotocol H.
JCO
Precis Oncol.
2026 Jan 14;10:e2500338.
doi:
10.1200/PO-25-00338. PMID:
41533998. Trial
registration ID:
NCT04439292. ˍ
Singh DJ, Prabhakar H, Kapoor I, Pandia MP, Pandey S.
Opioid-free
Anesthesia for Craniotomy in Supratentorial Tumors: An
Open-labeled Single-blinded Randomized Controlled Study.
J
Neurosurg Anesthesiol. 2026 Jan 15. doi:
10.1097/ANA.0000000000001089. PMID:
41537278.
Trial
registration ID:
CTRI/2022/08/044598. ˍ
Zhang J, Wang D, Liu G, Bu C, Lv G, Li M, Wei S, Zhang Z, Gao Y,
Yan Z, Ma C, Zhao R, Wang M, Shi Y, Bu X.
Dynamic
signature for the effectiveness of anti-PD-1 therapy combined with
vascular normalization therapy in recurrent glioblastoma: A
randomized phase 2 trial.
Cancer.
2026 Jan 15;132(2):e70253. doi:
10.1002/cncr.70253. PMID:
41533333.
Trial registration ID: Unidentified˰ ˍ
Çelebi A, Yıldırım B, Yıldırım
E, Işık S, Çoban E, Bıyıklı E,
Köstek O, Bayoğlu İV, Sarı M.
Adult-Onset
Diffuse Midline Glioma, H3K27-Altered: A Genomics-Guided,
Individualized, Multimodal Treatment Approach.
Brain
Sci. 2026 Jan 16;16(1):97. doi:
10.3390/brainsci16010097. PMID:
41594818. ˍ
Lind LM, Fischl A, Goettl E, Herr W, Kaiser U, Koelbl O, Linker R,
Maurer J, Riemenschneider MJ, Schmidt NO, Proescholdt M, Pukrop T,
Hau P, Rechenmacher M, Bumes E.
Palliative
care interventions and outcome in patients with glioblastoma - a
retrospective, single-center study.
BMC
Palliat Care. 2026 Jan 16;25(1):29. doi:
10.1186/s12904-026-01987-4. PMID:
41546074.
ˍ
Moraes FY, Isen J, Perry J, Laperriere N, Brandes A, Menten J,
Phillips C, Fay M, Nishikawa R, Mason WP, Cairncross JG, Roa W,
Ding K, O'Callaghan C.
Nomograms
for predicting survival of elderly patients with newly diagnosed
glioblastoma: a secondary analysis of the CCTG CE.6 trial.
J
Neurooncol. 2026 Jan 19;176(3):171. doi:
10.1007/s11060-025-05399-x. PMID:
41553596˰
ˍ
Nobre L, Ramaswamy V, Coleman C, Dhall G, Senapati A, Toledano H,
Jabado N, Bouffet E, Lafay-Cousin L.
High-dose
chemotherapy and craniospinal irradiation-sparing approach for WNT
medulloblastoma of early childhood.
J
Neurooncol. 2026 Jan 19;176(3):172. doi:
10.1007/s11060-026-05425-6. PMID:
41553441˰
ˍ